I heard this drug is going to be a blockbuster. Even better than Latuda. We have some kick-ass R&D people here, cranking out some great new drugs to sell!
SEP 289? That's been around since early 2000's. If it ever geta approved, how much patent life remains? Can't be much left?
It's launching in 2089 you idiot. We may get fast track approval since it is so cutting edge which may move approval up to 2087. You twit. 289 is a lingering pimple on the pock marked arse of this dying company. Nothing more and nothing less. Just pulling it out of the moth balls to keep the parent company thinking there will be life after Latuda.
